There are roughly 2,400 U.S.-listed companies with market caps under $300 million. Most sell-side shops don't cover them. Most financial media doesn't either. MicroCap Desk exists because that's where the information asymmetry still lives — and where the best and worst stories in public markets are hiding.
Every weekday, MicroCap Desk publishes roughly ten dispatches on individual microcap companies. Each piece covers a real, recent catalyst — an earnings release, a clinical readout, a contract win, a going-concern filing, an insider buy, an S-3 shelf — and attempts to answer the one question that matters: what actually happened, and what does it mean for the business 12 months out?
We don't write ratings. We don't publish price targets. We assign each story a sentiment — bullish, bearish, or neutral — which reflects the direction our reporting points, not a recommendation to trade.
Three structural reasons the segment is worth writing about.
First, coverage drought. The average S&P 500 company is covered by 28 sell-side analysts. The average sub-$100M microcap is covered by zero. When a company with a $60M market cap announces a pivotal trial result or a Department of Defense contract, it often takes retail investors days — sometimes weeks — to figure out what the announcement actually means. That's not a knock on retail. It's a function of there being no intermediary layer translating 8-Ks into English.
Second, dispersion. Microcap returns are bimodal. The median microcap loses money over any given five-year window; the top decile compounds at rates that dwarf large-cap indexes. That's exactly the distribution where careful single-name research pays off — and where the downside of being wrong is real, which keeps you honest.
Third, the stories are just more interesting. A microcap company is usually one person's vision, one technology, one geography. A large cap is a portfolio of businesses run by a risk committee. There's simply more narrative density per column-inch down here.
Every number in our pieces traces back to a primary document — 10-K, 10-Q, 8-K, S-1, proxy. Press releases are starting points, not conclusions.
Share-count trajectory is the single most under-discussed variable in microcap analysis. We show it on every piece where it's material.
We paraphrase executives from earnings calls and filings. We do not invent quotes. Ever. If a quote appears in quotes, it was said or written.
Our archive carries corrections, not silent edits. If the original article got it wrong, the correction gets the same prominence.
We don't accept payment from the companies we cover. We don't sell sponsored posts. We don't participate in IR roadshows or take meetings with management ahead of publication. We don't front-run our own publications — our staff are prohibited from trading the names we cover for a defined window around publication, and we disclose any position the desk holds at the bottom of every piece. If that window rule seems strict, it's because the alternative is the business model that killed most independent financial media.
MicroCap Desk is written by a small editorial team with prior experience in buy-side research, financial journalism, and SEC filings work. We're deliberately keeping the masthead small so that every dispatch gets edited by someone who has read the 10-K cover-to-cover — not just the MD&A section.
For now, pieces are bylined "The Desk" rather than individual reporters. This will change as the site scales; for the moment, it reflects that every piece is genuinely a product of the full team rather than any single writer's view.
If you've seen something in a filing that doesn't add up, or you know a microcap name that should be on our radar, we want to hear from you. Tips are confidential by default. Reach us at tips@microcapdesk.com or through the contact page.